Category Archives: MS Treatment

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (TEVA) today announced that key data from the Companys multiple sclerosis (MS) franchise will be featured at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Lyon, France, October 10-13, 2012. Data presentations will provide new insights on COPAXONE (glatiramer acetate injection), the worlds leading relapsing-remitting multiple sclerosis (RRMS) treatment, and Tevas investigational oral compound laquinimod, as well as results from the ongoing TOP MS and NARCOMS studies. "For more than 20, years Teva has been at the forefront of MS research and development focused on providing effective and safe treatments aimed at meeting the needs of patients living with this complex, often debilitating disease, said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer for Teva Pharmaceutical Industries Ltd. The data being presented at ECTRIMS demonstrate our ongoing commitment to enhancing the treatment experience for RRMS patients and advancing science to assist neurologists in making appropriate treatment decisions, especially as the market continues to evolve. In addition to the data being presented at the Congress, Teva will host a satellite symposium, New Concepts in MS Pathology Shed Light on MS Treatment Approaches on Thursday, … Continue reading →

LOS ANGELES, CA--(Marketwire - Oct 5, 2012) - Fresh Start Private Management Inc. ( OTCQB : CEYY ), a leader in alcohol treatment and rehabilitation, is honored to announce that Ms. Lourdes Felix has been appointed the new Chief Financial Officer. The Board of Directors are happy to appoint Ms. Felix as the new Chief Financial Officer. Ms. Felix will assume the role of Chief Financial Officer from Mr. Jorge Andrade who has been the acting Chief Financial Officer for the Company. Mr. Andrade will remain as the CEO and a member board of directors. Ms. Felix received her accounting degree from University of Phoenix and has been working in the public and private accounting sector since 1991. Mr. Jorge Andrade, Chief Executive Officer, said, "We value her professionalism and deep knowledge of finance and accounting. Her corporate experience and impressive track record are a key part of creating a sophisticated executive team." For more information on CEYY, please visit http://www.freshstartprivate.com About Fresh Start Private Fresh Start Private is an alcohol treatment and rehabilitation company that is on the leading edge of alcohol addiction treatment. Fresh Start Private has developed an implant and treatment program that is highly effective in … Continue reading →

Oct. 3, 2012 -- There is growing evidence that infertility treatments raise relapse rates in women with multiple sclerosis. In a new study, 3 out of 4 women with MS had increased disease activity following assisted reproductive technology (ART) infertility treatments. The study was small, with just 16 infertile MS patients getting the treatments. But a second study with twice as many patients, published just a few months ago, also suggested that infertility treatments can bring on or worsen MS symptoms. Timothy Coetzee, PhD, who is chief research officer for the National MS Society, says it is increasingly clear that hormones -- particularly sex hormones -- play an important role in MS. This research highlights an issue that needs further study, he says. When we manipulate hormones to achieve a pregnancy, there may be a significant impact on MS symptoms. Multiple sclerosis is an autoimmune disease that affects about 400,000 people in the U.S. and 2.5 million people worldwide. Twice as many women as men are diagnosed.Women are often diagnosed in their childbearing years. Most women with MS are no more likely to suffer from infertility as other women. But fertility can be affected in women treated with certain MS … Continue reading →

ScienceDaily (Oct. 3, 2012) Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity. Study findings published in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggest reproductive hormones contribute to regulation of immune responses in autoimmune diseases such as MS. According to a 2006 report from the World Health Organization (WHO), MS affects 2.5 million individuals worldwide and is more common among women than men. While previous research found that up to 20% of couples in Western countries experience infertility, women with MS typically do not have diminished fertility except in those treated with cyclophosphamide or high-dose corticosteroids. Medical evidence shows sex hormones and those involved in ovulation (gonadotrophin-releasing hormone (GnRH)) play an important role in the development of autoimmune disorders. "When MS and infertility coincide, patients seek ART to achieve pregnancy," explains Dr. Jorge Correale with the Ral Carrea Institute for Neurological Research in Buenos Aires. "Given the role of some reproductive hormones in autoimmune diseases, those with MS receiving infertility treatments are at particular risk of exacerbating their disease." To further understand the impact of infertility … Continue reading →

02.10.2012 - (idw) Julius-Maximilians-Universitt Wrzburg In patients suffering from multiple sclerosis, the brain is capable of compensating for certain disorders to some extent. How it does this has been examined in detail by medics from Wrzburg University Hospital. Their findings may help to improve treatment. Patients who suffer from multiple sclerosis (MS) typically present with centers of inflammation in the brain and spinal cord, which cause symptoms that range in severity depending on site and size. For example, sufferers feel a tingling sensation in their extremities, they stumble more or they have difficulties seeing. In extreme cases, they become incapable of moving around on their own and are confined to a wheelchair. How the brain compensates for damage The brain, however, often manages to minimize the functional damage caused by such centers, i.e. the damage that is noticeable to the patient. It has various tools at its disposal for this purpose: firstly, processes that are based on a rapid reinforcement or reduction of nerve cell contacts; secondly, the transfer (usually with a delay) of certain tasks from the damaged region of the brain to a healthy one. Plasticity is the name science has given to this ability on the part … Continue reading →

28-09-2012 01:49 http://www.AskTheDoctor-MS.com. Dr. Kurt Woeller is a complementary medical specialist focusing on neurological disorders including treatment for multiple sclerosis. Dr. Woeller's biomedical therapies focus on treatments with respect to diet, detoxification, auto-immune system and the hormone system with personalized integrated protocols to help treat multiple sclerosis issues. Visit http to learn more about health and treatment topics related to multiple sclerosis. View original post here: About Dr. Kurt Woeller - Video … Continue reading →

27-09-2012 22:09 http://www.AskTheDoctor-MS.com. Dr. Kurt Woeller explains complementary medical treatments available for those suffering with Multiple Sclerosis, including supplements, dietary changes, detoxification, herbal remedies and more. Many patients have benefitted greatly by adding complementary medicine to their regimen. For more information, visit http See the original post: Treatment Options for Multiple Sclerosis - Video … Continue reading →

Brandon Sun - ONLINE EDITION By: Larry Kusch 28/09/2012 8:11 AM | Comments: 0 There will be no Manitoba-sponsored clinical trials of a new treatment for multiple sclerosis, but Health Minister Theresa Oswald says MS sufferers should not despair. The province is close to negotiating an arrangement with a Canadian group that would include Manitobans in a national study of the efficacy of the liberation treatment for MS, Oswald said Thursday. Earlier in the day, the Manitoba Health Research Council (MHRC) revealed it received only one application to conduct clinical trials for the new procedure and had found it wanting. A review committee examined the proposal and "based on the criteria that had been established, had just deemed that it was not good enough to go forward," said MHRC executive director Christina Weise. Instead, the research council recommended Manitoba partner with MS clinical trials organized by the Canadian Institutes of Health Research. Oswald said discussions with that group are well underway. "I'm extremely optimistic that we're going to be able to find a way for Manitobans to become part of the clinical study here in Canada," she said from Halifax, where she was attending a meeting of provincial and territorial … Continue reading →

Brandon Sun - ONLINE EDITION By: Staff Writer 28/09/2012 12:16 PM | Comments: 0 ADRIAN WYLD / THE CANADIAN PRESS Enlarge Image Minister of Health Leona Aglukkaq A national clinical trial to test a controversial treatment for multiple sclerosis has received the necessary medical and ethical approvals to proceed, federal Health Minister Leona Aglukkaq announced today. Recruitment for participants will begin Nov. 1 in Vancouver and Montreal. Participants will also be sought in Winnipeg and Quebec City, once ethics approval is granted for these centres to join. That could occur later in November. Altogether, 100 MS patients will take part in the first phase of the clinical trials. Dr. Anthony Traboulsee, medical director of the UBC Hospital MS Clinic, and his collaborators received ethics approvals from institutions in British Columbia and Qubec to undertake the clinical trial for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in persons with multiple sclerosis (MS). CCSVI is a term used to describe the problem with blood flow in neck veins. Some doctors believe it plays a role in causing MS. Here is the original post: National trials for CCSVI treatment for MS patients to begin in November … Continue reading →

TORONTO Multiple sclerosis patients in B.C. will be part of a federal government trial of a controversial experimental treatment. Researchers will begin recruiting patients Nov. 1 to study the treatment for chronic cerebrospinal venous insufficiency, or CCSVI, Health Minister Leona Aglukkaq said Friday. That treatment involves unblocking neck veins that Italian vascular surgeon Paolo Zamboni has suggested could be a cause of MS. About 100 patients are expected to take part in the trial to be conducted in B.C. and Quebec. Vancouver MS researcher Dr. Anthony Traboulsee will head the $6-million study being funded by Ottawa, the MS Society of Canada and the provinces where the trial will take place. Traboulsee said researchers will monitor MS patients over a two-year period in order to obtain scientific evidence on the safety and efficacy of the CCSVI procedure. Copyright (c) Go here to read the rest: MS patients in B.C. part of trial on experimental treatment … Continue reading →